Penumbra could generate healthy sales and earnings growth, gaining market share in MT. MT’s share would rise to around 50% in DVT and about 60% in PE. Don’t miss this list of 3 high-yield ...
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 2.54% ...
Penumbra, Inc. PEN recently announced the FDA’s clearance and the launch of Lightning Flash 2.0, the next generation computer assisted vacuum thrombectomy (CAVT) system to remove venous thrombus and ...
Penumbra, Inc. (NYSE:PEN) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company announced the completion of enrollment in STORM-PE clinical trial. The pivotal, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min At Penumbra Inc. Shruthi Narayan ...
Boston Scientific has agreed to acquire Penumbra in a cash and stock deal worth roughly $14.5 billion. The transaction values Penumbra at $374 per share. Penumbra has developed a comprehensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results